Voltage-gated calcium channel ␣1 subunits consist of four domains (I-IV), each with six transmembrane segments. A number of truncated isoforms have been identified to occur as a result of alternative splicing or mutation. We have examined the functional consequences for expression of full-length Ca v 2.2 (␣1B) of its coexpression with truncated constructs of Ca v 2.2. Domains I-II or domains III-IV, when expressed individually, together with the accessory subunits ␤1b and ␣2␦-1, did not form functional channels. When they were coexpressed, lowdensity whole-cell currents and functional channels with properties similar to wild-type channels were observed. However, when domain I-II, domain III-IV, or domain I alone were coexpressed with full-length Ca v 2.2, they markedly suppressed its functional expression, although at the single channel level, when channels were recorded, there were no differences in their biophysical properties. Furthermore, when it was coexpressed with either domain I-II or domain I, the fluorescence of green fluorescent protein (GFP)-Ca v 2.2 and expression of Ca v 2.2 protein was almost abolished. Suppression does not involve sequestration of the Ca v ␤ subunit, because loss of GFP-Ca v 2.2 expression also occurred in the absence of ␤ subunit, and the effect of domain I-II or domain I could not be mimicked by the cytoplasmic I-II loop of Ca v 2.2. It requires transmembrane segments, because the isolated Ca v 2.2 N terminus did not have any effect. Our results indicate that the mechanism of suppression of Ca v 2.2 by truncated constructs containing domain I involves inhibition of channel synthesis, which may represent a role of endogenously expressed truncated Ca v isoforms.
Voltage-gated calcium channels subserve a number of f unctions, including neurotransmitter release, regulation of gene transcription, and muscle contraction (C atterall, 2000) . They are heteromeric complexes consisting minimally of three subunits, namely the pore-forming ␣1 subunit and the accessory ␤ and ␣2-␦ subunits. The ␣1 subunit is the structural and f unctional core of the channel and consists of four homologous domains (Dom I-IV), linked by intracellular loops and with intracellular N and C termini. Each domain contains six transmembrane-spanning segments (S1-S6). To date, 10 ␣1 subunits have been cloned and expressed (Birnbaumer et al., 1994; Perez-Reyes and Schneider, 1994; C atterall, 2000) , termed ␣1A-␣1I and ␣1S, now renamed C a v 1-3 (Ertel et al., 2000) .
Mutations in calcium channel ␣1 subunits can contribute to a number of pathological states, and some of these mutations involve the introduction of a premature stop codon. For example, in episodic ataxia type-2 (EA-2), a number of mutations in the C a v 2.1 subunit predict truncated forms of this channel (Ophoff et al., 1996; Denier et al., 1999) . Most identified mutations in EA-2 introduce stop codons at the end of domain II-S6, in domain III-S1, and in the S1 segments of domains III and IV. The truncation at S1 of domain III is of particular interest because a 95 kDa protein has been identified that normally copurifies with C a v 2.1 (Scott et al., 1998) . This protein appears to contain domains I, II, and part of the II-III loop of C a v 2.1. Thus, it is very similar to the predicted truncation in EA-2. To date, no naturally occurring two-domain splice variants of C a v 2.1 that would give rise to such a twodomain protein product have been found. Recently, novel splice variants of C a v 1.2 have been identified, generated by alternative splicing in the II-III loop, which predict two truncated forms of C a v 1.2, consisting of domains I and II (Wielowieyski et al., 2001) . In addition, a splice variant of C a v 2.2 has been identified in humans and rodents that would introduce a stop codon near the end of the II-III loop (Mittman, Agnew, 2000) . The expression of this splice variant would give rise to a protein consisting of domains I and II of C a v 2.2. Little is known about the tissue-specificity or developmental regulation of expression of such splice variants, except that an isoform consisting of the first two domains of C a v 1.1 is the main transcript in newborn muscle, whereas the four-domain isoform is predominant in adult muscle (Malouf et al., 1992) . Furthermore, it has recently been found that during development of a tunicate tadpole, a truncated calcium channel with homology to C a v 1.1, consisting of domains III and IV with part of domain II was expressed from a maternal transcript (Okagaki et al., 2001) .
In the present study, we have examined the expression, physiological function, and effects on channel protein levels of truncations of the N-type calcium channel Ca v 2.2. Our results indicate that constructs containing transmembrane domain I suppress the synthesis of full-length Ca v 2.2.
MATERIALS AND METHODS

Materials.
The following cDNAs were used: rat ␤1b (Tomlinson et al., 1993) , rabbit C a v 2.2 (D14157), rat ␣2␦-1 (M86621), and green fluorescent protein (GFP) mut3b (Cormack et al., 1996) .
Truncated Ca v 2.2 channel constructs. Constructs containing different domains of the rabbit C a v 2.2 channel were made using the PCR with primers incorporating either start or stop codons and restriction enzyme sites. The following primers were used: N-term (forward): 5Ј-GCG AC T AGT ATG GTC CGC TTC GGG GAC Ϫ3Ј and (reverse): 5Ј-GTA C TC GAG CTA AGG CCA C TC GGT GAT GCG-3Ј (introduces a stop codon at the end of the N terminus); Dom I (reverse): 5Ј-TTA AC T AGT TTA C TG TGC C TT CAC CAT GCG-3Ј (introduces a stop codon at the end of the I-II loop); Dom I-II (reverse): 5Ј-C TC GAC TAG TTA CAT GGT CAC AAT GTA GTG-3Ј (introduces a stop codon at the end of the II-III loop); Dom III-IV (forward): 5Ј-TGG CCA C TA GTA TGG ACA ACC TTG CCA ATG-3Ј (introduces a start codon at the beginning of the II-III loop).
In the GFP-Ca v 2.2, the stop codon of GFP was removed, and GFP was f used to the N terminus of C a v 2.2 by PCR. The sequence for the forward primer was 5Ј-GAT GA A CTA TAC A A A ATG GTC CGC TTC GG-3Ј. The sequence in italics indicates the end of GFP (with the stop codon removed), and the underlined sequence indicates the beginning of Ca v 2.2. GFP was fused to the Dom I-II construct using the same primer. Enhanced yellow fluorescent protein (EYFP) (Clontech, Cowley, UK) was fused onto the N terminus of the Dom I construct using the primer, 5Ј-GAG CTG TAC A AG TCC GGA ATG GTC CGC TTC GGG-3Ј. The sequence in italics indicates the end of EYFP, and the underlined sequence indicates the beginning of Ca v 2.2. For the I-II loop construct, the following primers were used: 5Ј-GGAGAATTCGCTATGGAGCGCGAGAGAGTG-3Ј (forward with an EcoRI site and a start codon) and 5Ј-CTGTGCTCTAGACAT-GCGCCGGATG-3Ј (reverse with an incorporated XbaI site). The resulting fragment was digested with EcoRI and XbaI enzymes and ligated in frame with the myc-and His-tags of pcDNA3.1/myc-His(ϩ)A (Invitrogen, Paisley, UK) vector. The validity of the construct was f urther confirmed by Western blot, probed with anti-His antibodies (Abs) (Santa Cruz Biotechnology, Santa Cruz, CA), after expression in C OS-7 cells. The sequences of all constructs were verified by automated sequencing.
Yeast two-hybrid screening. Yeast two-hybrid studies were performed using the Matchmaker Gal4 system (C lontech). The N terminus of Ca v 2.2 was made by PCR using a forward primer against the vector and the reverse primer: 5Ј GAT C TC GAG AGG CCA C TC GGT GAT GCG 3Ј. This gave a product with an NcoI site overlapping the 5Ј ATG start codon and an XhoI site at the 3Ј end. The digested PCR product was subcloned into the NcoI-XhoI sites of pAC T2 and the NcoI-SalI sites of pAS2-1. The constructs containing the C terminus and the I-II loop were made using the following primers: C terminus: 5Ј GTG ACC ATG GAC AAT TTT GAG TAC C 3Ј and 5Ј TAT CGA ATT C TA GCA CCG GCG GTC G 3Ј; I-II loop: 5Ј GTA ACC ATG GC T AAG GAG CGC GAG AG 3Ј and 5Ј GTA GGA AAT C TG TGC C TT CAC CAT GC 3Ј. These PCR products, as well as the entire calcium channel ␤1b subunit, were subcloned into the NcoI-EcoRI sites of both pAC T2 and pAS2-1. Competent yeast cells (Y190 strain) were cotransformed with both plasmids, and ␤-galactosidase colony-lift filter assays were performed according to the user manual (C lontech).
Cell culture and transfection. C OS-7 cells were cultured as previously described (C ampbell et al., 1995) and transfected using the Geneporter transfection reagent (Qbiogene, Harefield, UK). C ells were plated onto coverslips 2-3 hr before transfection. The cDNAs (all at 1 g /ml) for Ca v 2.2 or truncated domain constructs (Dom I, I-II, III-IV, N terminus, or I-II loop), ␣2␦-1, ␤1b, and GFP (when used) were mixed in a ratio of 1.5 (or 3):2:1:0.2. When both C a v 2.2 and truncated construct were both present, the ratios were 1.5:1.5:2:1:0.2. When particular subunits were not used, the volume was made up with water. The DNA mixture and Geneporter (6 g and 30 l, respectively) were each diluted in 500 l of serum-free medium, mixed, and applied to the cells. After 3.5 hr, 1 ml of medium containing 20% serum was added to the cells, which were then incubated at 37°C for 3 d, followed by incubation at 27°C, where stated. Lactacystin (C N Biosciences, Beeston, UK) was stored at Ϫ20 O C as a 3 mM stock solution in dimethylsulfoxide (DMSO) and, when used, was added to the transfected cells at 30 M.
Immunoc ytochemistr y and confocal microscopy. C OS-7 cells were washed twice in Tris-buffered saline (TBS; 154 mM NaC l, 20 mM Tris, pH 7.4), then fixed in 4% paraformaldehyde in TBS as described (Brice et al., 1997) . The cells were permeabilized in 0.02% Triton X-100 and incubated with blocking solution [20% (v/ v) goat serum, 4% (w/ v) bovine serum albumin (BSA), and 0.1% D,L-lysine in TBS]. In experiments using mouse monoclonal anti-GFP Ab (C lontech), or anti-myc Ab (9E10; Santa Cruz), they were used at 20 and 0.4 g /ml, respectively, and the secondary Ab was 10 g /ml goat anti-mouse IgG conjugated to Texas Red (Molecular Probes, Eugene, OR). In some experiments, cells were incubated for 20 min with Texas Red phalloidin (6.6 M; Molecular Probes). The nuclear dye 4Ј,6-diamidino-2-phenylindole (DAPI; 300 nM; Molecular Probes) was also used to visualize the nucleus. C ells were then washed in TBS five times for 5 min each. Coverslips were mounted directly onto a microscope slide with Vectorshield (Vector Laboratories, Burlingame, CA), and the cells were examined on a laser-scanning confocal microscope (Leica TC S SP; Leica, Milton Keynes, UK). The optical sections were 0.2 m, and all images were scanned sequentially to eliminate cross-talk. For the immunocytochemistry experiments, n ϭ number of different transfections performed, with at least two coverslips of cells analyzed per transfection condition.
Western blotting. C OS-7 cells were resuspended in hypotonic buffer (10 mM Tris, pH 7.4), containing protease inhibitors (complete EDTA-free; Roche Diagnostics, Lewes, UK) and 2 mM EDTA. Aliquots were taken for assay of total lysate protein (BCA; Perbio Science, Chester, UK), and the remainder of each sample was then solubilized in SDS-PAGE sample buffer containing 2% SDS. The samples were sonicated briefly (three times for 5 sec each on ice) and then centrif uged (10,000 ϫ g, 15 min, 4°C) to remove any insoluble material. Samples (50 g of total protein / lane) were separated by SDS-PAGE using 7.5% resolving gels and then transferred electrophoretically to poly vinylidene fluoride membranes. The membranes were blocked with 3% BSA for 5 hr at 55°C and then incubated overnight at 20°C with a 1:1000 dilution of either anti-GFP monoclonal Ab, or an anti-peptide Ab raised in rabbits against residues 846 -861 within the II-III loop of rabbit brain C a v 2.2 and purified by affinity chromatography using the immobilized synthetic peptide. Secondary Ab (a 1:1000 dilution of goat anti-mouse IgG or goat anti-rabbit IgG horseradish peroxidase conjugate, respectively) was added, and the membranes were incubated for 1 hr. After extensive washing, bound Abs were detected using enhanced chemiluminescence (Amersham Pharmacia Biotech, Little Chalfont, UK).
W hole-cell electrophysiolog y. Whole-cell patch-clamp recording was performed essentially as previously described (Meir et al., 2000) , with 10 mM Ba 2ϩ as charge carrier. Only fluorescent cells expressing GFP were used for recording. The holding potential was Ϫ100 mV, and pulses were delivered every 10 sec. Currents were measured 10 msec after the onset of the test pulse, and the average over a 2 msec period was calculated and used for subsequent analysis. The current density -voltage ( I-V) relationships were fitted with a modified Boltzmann equation as follows:
where I is the current density (in picoamperes per picofarad), G max is the maximum conductance (in nanosiemans per picofarad), V rev is the reversal potential, V 50,act is the midpoint voltage for current activation, and k is the slope factor. Data are expressed as mean Ϯ SEM of the number of replicates, n. Steady-state inactivation properties were measured by applying 10 sec pulse from Ϫ120 to ϩ10 mV in 10 mV increments, followed by a 10 msec repolarization to Ϫ100 mV before the 40 msec test pulse to ϩ20 mV. Steady-state inactivation data were fitted with a single Boltzmann equation of the form:
where I max is the maximal current, V 50,inact is the half-maximal voltage for current inactivation, k inact is the slope factor, and A 1 and A 2 represent the proportion of inactivating and noninactivating current, respectively.
Single-channel electrophysiolog y. Recordings were performed on GFPpositive cells at 20 -24°C. Recording pipettes were pulled from borosilicate tubes (World Precision Instruments, Sarasota, FL), coated with Sylgard (Sylgard 184, Dow Corning, Wiesbaden, Germany), and firepolished. The bath solution, designed to zero the resting membrane potential (Meir and Dolphin, 1998) was composed of (in mM): 135 K-aspartate, 1 MgC l 2 , 5 EGTA, and 10 H EPES (titrated with KOH, pH 7.3), and the patch pipettes were filled with a solution of the following composition (in mM): 100 BaC l 2 , 10 TEA-C l, and 10 H EPES, with 200 nM TTX, titrated with TEA-OH to pH 7.4. Both solutions were adjusted to an osmolarity of 320 mOsmol with sucrose. Data were sampled at 10 kHz and filtered on-line at 2 kHz. (Axopatch 200B and Digidata 1200; Axon Instruments, Foster C ity, CA). Voltages were not corrected for liquid junction potential (Neher, 1995) , measured to be Ϫ15 mV in these solutions.
Leak subtraction was performed as described (Meir et al., 2000) . Event detection was performed using the half-amplitude threshold method. Open time was determined by a single or double exponential fit to the open time distributions. C losed times were determined similarly using only patches with no overlapping openings. The latency to first opening was measured in 2 msec bins and analyzed as described (Meir et al., 2000) . In brief, first latency histograms were accumulated and divided by the number of episodes, to represent the cumulative probability of a first latency event (P FL ). If necessary these were corrected for the number of channels in the patch. We considered the number of detectable simultaneously overlapping openings as representing the number of channels active in the patch (Meir et al., 2000) . To strengthen this assumption we included in the latency analysis only patches with up to three simultaneously overlapping openings.
RESULTS
Expression of GFP-Ca v 2.2 and truncated constructs
The functional expression of Ca v 2.2 in COS-7 cells was investigated using N terminal GFP-fusion proteins of Ca v 2.2 and several truncated forms. We first examined whether the GFP-tagged Ca v 2.2, expressed in combination with the accessory subunits ␤1b and ␣2␦-1, was able to reproduce the biophysical properties of wild-type Ca v 2.2. An example of a whole-cell recording of I Ba from COS-7 cells transfected with GFP-Ca v 2.2 cDNA is shown in Figure 1a (top panel ), together with the voltage protocol used. The I-V relationship for the GFP-tagged Ca v 2.2 is shown in Figure 1b ( filled circles). The GFP tag on the N terminus did not interfere with the functionality of the channel, because the current density at ϩ20 mV was Ϫ55.1 Ϯ 8.3 pA/pF for the untagged Ca v 2.2 channel (n ϭ 12; data not shown), not significantly different from the GFP-Ca v 2.2 channel (Ϫ59.2 Ϯ 17.9 pA/pF; n ϭ 10). Similarly, there were no differences in other parameters of the I-V relationship (see legend to Fig. 1 ).
GFP-Dom I-II, containing only the first two domains and the intracellular II-III loop of Ca v 2.2, when expressed with ␤1b and ␣2␦-1, did not elicit any detectable currents (Fig. 1b, open circles) . The same was true for Dom III-IV, indicating that the hemichannels are unable to form functional channels alone. In contrast, coexpression of the two hemichannels (either with or without a GFP tag on Dom I-II) resulted in the reproducible expression of small whole-cell currents, with properties otherwise analogous to the native Ca v 2.2 (Fig. 1a , middle and bottom panels). In cells expressing untagged Dom I-II and Dom III-IV, a ϩ20 mV step elicited a current of Ϫ13.2 Ϯ 4.2 pA/pF (n ϭ 8). Coexpression of the GFP-Dom I-II with Dom III-IV resulted in the expression of currents with similar amplitude at ϩ20 mV (Ϫ11.4 Ϯ 3.8 pA/pF; n ϭ 7). In addition, the steady-state inactivation properties of the reconstituted channel composed of Dom I-II and Dom III-IV did not differ from those of GFP-Ca v 2.2 (Fig. 1c) . . Cells held at Ϫ100 mV. Test potentials Ϫ50 to ϩ70 mV (only traces between Ϫ20 and ϩ10 mV shown). Asterisks indicate GFP tag. b, Mean I-V relationships for GFP-Ca v 2.2 (F; n ϭ 10); GFP-Dom I-II and Dom III-IV (‚; n ϭ 6), and Dom I-II and Dom III-IV ({; n ϭ 8);. I Ba at ϩ20 mV was Ϫ59.2 Ϯ 17.9 pA/pF (n ϭ 10) for GFP-Ca v 2.2 and Ϫ55.1 Ϯ 8.3 pA/pF for untagged Ca v 2.2 (n ϭ 12; p ϭ NS; data not shown). The I-V parameters were also unaltered for both V 50,act (ϩ8.8 Ϯ 1.5 mV for Ca v 2.2 and ϩ3.0 Ϯ 3.0 mV 4 for GFP-Ca v 2.2; p ϭ NS) and k (ϩ4.4 Ϯ 0.5 for Ca v 2.2 and ϩ3.3 Ϯ 0.5 for GFP-Ca v 2.2; p ϭ NS). For untagged Dom I-II and Dom III-IV, I Ba at Ϫ20 mV was Ϫ13.2 Ϯ 4.2 pA/pF, and the I-V parameters were: V 50,act ϭ ϩ11.5 Ϯ 2.8 mV, k ϭ ϩ4.8 Ϯ 0.6 ( p ϭ NS; compared with Ca v 2.2). GFP-Dom I-II plus Dom III-IV gave similar results (I Ba was Ϫ11.4 Ϯ 3.8 pA/pF) with slight shift of V 50,act (ϩ15.0 Ϯ 2.0 mV; p Ͻ 0.05 compared with GFP-Ca v 2.2) and an increase in k (ϩ5.4 Ϯ 0.4 mV; p Ͻ 0.01). When either Dom I-II or Dom III-IV were expressed alone, no current was detected (E; n ϭ 6). c, Steady-state inactivation curves for GFP-Ca v 2.2 (F) and Dom I-II plus Dom III-IV (छ) together with fits (solid lines). V 50,inact was Ϫ38.6 Ϯ 0.9 mV for GFP-Ca v 2.2 (n ϭ 5) and Ϫ40.1 Ϯ 1.3 mV for Dom I-II plus Dom III-IV (n ϭ 5; p ϭ NS), whereas k inact values were ϩ9.8 Ϯ 0.8 and ϩ10.9 Ϯ 1.1, respectively ( p ϭ NS).
Once the functional integrity of the GFP-tagged channel and hemichannels was proven, the expression of these fusion proteins was examined using confocal microscopy. Figure 2a shows the localization of GFP-Ca v 2.2. This subunit was expressed throughout the cell (Fig. 2a , left panel ) (n Ͼ 10). The cells were also stained with Texas Red phalloidin to visualize cortical actin, which delineates the plasma membrane (Fig. 2a, middle panel ) . The yellow color in the merged image (arrow) indicates that GFP-Ca v 2.2 and Texas Red phalloidin are colocalized at the plasma membrane (Fig. 2a, right panel ) , in accordance with the electrophysiological results.
Effect of coexpression of two domain constructs on Ca v 2.2 localization
Having determined the distribution of full-length GFP-Ca v 2.2, we next investigated the effect of Dom I-II or Dom III-IV on the expression of GFP-Ca v 2.2. As shown in Figure 2b , untagged Dom I-II strongly suppressed the expression of GFP-Ca v 2.2 (n ϭ 6). This was evidenced by the complete absence of observable GFP-positive cells. This could be attributable to a low level of expression, below the detection capability of the imaging system. Thus, an anti-GFP Ab was used to amplify the signal of any expressed GFP-Ca v 2.2 within the cells. The anti-GFP Ab was able to detect GFP-Ca v 2.2 alone (Fig. 2c) ( n ϭ 4), but no staining was detectable when GFP-Ca v 2.2 was coexpressed with Dom I-II (Fig. 2d , center panel ) ( n ϭ 4). In this case, the presence of viable cells was established by using the nuclear stain DAPI (Fig. 2d, right panel ) . These results confirm that Dom I-II greatly reduces the expression of GFP-Ca v 2.2.
When GFP-Dom I-II was expressed alone, it was detectable at the plasma membrane and throughout the cell (Fig. 2e , right panel ). The subcellular localization of GFP-Dom I-II was identical to that of GFP-Ca v 2.2 (n Ͼ 10). Interestingly, in the converse of the coexpression study described above, the expression of GFP-Dom I-II was not detectably reduced by the presence of untagged Ca v 2.2 (Fig. 2f ) .
The coexpression of GFP-Dom I-II with Dom III-IV did not alter the GFP expression or localization of GFP-Dom I-II (results not shown; n ϭ 6). In contrast, coexpression of GFP-Ca v 2.2 with Dom III-IV altered the expression of GFP-Ca v 2.2 within individual cells, but did not entirely suppress it (Fig. 2g) (n ϭ 6) . In this case, GFP-Ca v 2.2 showed a perinuclear localization and was not readily detectable throughout the cytoplasm or at the plasma membrane by confocal microscopy (Fig. 2g) .
Functional effects of coexpression of two-domain constructs with Ca v 2.2
Although immunofluorescence studies indicated that Dom I-II completely suppressed the expression of GFP-Ca v 2.2, it was plausible that small amounts of GFP-Ca v 2.2 were still expressed. This was confirmed by whole-cell recording, which showed that there was a marked reduction in I Ba current density in cells expressing GFP-Ca v 2.2 together with either Dom I-II or Dom III-IV (Fig. 3a) , although the I-V parameters were unchanged (Fig. 3b) . I Ba at ϩ20 mV was Ϫ59.2 Ϯ 17.9 pA/pF for GFPCa v 2.2, and was reduced to Ϫ19.2 Ϯ 3.6 pA/pF when GFPCa v 2.2 was coexpressed with Dom I-II (67% reduction; n ϭ 26; p Ͻ 0.001) and Ϫ18.1 Ϯ 6.1 pA/pF with Dom III-IV (69% reduction; n ϭ 12; p Ͻ 0.001). The steady-state inactivation parameters for Ca v 2.2 were also unchanged by coexpression with Dom I-II (Fig. 3c) . Because of the suppression effect, it was necessary to coexpress free GFP, to facilitate the identification of successfully transfected cells. This did not alter the amplitude of control Ca v 2.2 currents (data not shown). We also examined whether the effect of Dom I-II was a nonspecific result of coexpressing another transmembrane protein, but no reduction in I Ba was observed when Ca v 2.2 was coexpressed with the ␣2A-adrenergic receptor under the same conditions (I Ba ϭ Ϫ80.1 Ϯ 24.1 pA/pF at ϩ20 mV; n ϭ 6). We further assessed whether the decrease in Ca v 2.2 current amplitude when it was coexpressed with Dom I-II could be a result of an alteration of the ratio between the Ca v 2.2 and truncated construct cDNAs transfected. Therefore I Ba was examined in cells transfected with half of the normal amount of GFP-Ca v 2.2-pMT2 cDNA (1.5 g/dish), with the same amount of accessory subunits. No reduction in current amplitude or alteration in I-V parameters were detected (data not shown), indicating that the Ca v 2.2 cDNA amount was saturating, consistent with the fact that COS-7 cells are SV40 transformed, and the vector pMT2 contains the SV40 origin of replication. We I Ba at ϩ20 mV was Ϫ19.2 Ϯ 3.6 pA/pF for GFP-Ca v 2.2 plus Dom I-II (n ϭ 26; p Ͻ 0.001; compared with control) and Ϫ18.1 Ϯ 6.1 pA/pF for GFP-Ca v 2.2 plus Dom III-IV (n ϭ 12; p Ͻ 0.001). The respective V 50,act ϭ ϩ5.2 Ϯ 0.3 mV and ϩ 7.7 Ϯ 0.8 mV. Controls (F; n ϭ 10) are the same as for Figure 1 because the experiments were all performed in parallel. c, Steady-state inactivation for GFP-Ca v 2.2 plus Dom I-II. V 50,inact ϭ Ϫ37.8 Ϯ 0.8 mV; k inact ϭ ϩ9.2 Ϯ 0.7; n ϭ 6; p ϭ NS compared with GFP-Ca v 2.2 (Fig. 1) . d, Effect of transfection of different amounts (the standard amount, 1 g, Ⅺ; or 1.7 g/dish, f) of ␤1b cDNA on I Ba for GFP-Ca v 2.2 plus Dom I-II. When using 1.7 g ␤1b cDNA, I Ba was Ϫ19.4 Ϯ 10.7 at ϩ20 mV, and V 50,act was ϩ10.3 Ϯ 0.3 mV, (n ϭ 8). e, I-V relationships for Ca v 2.2 alone (F; n ϭ 9) or plus myc-tagged I-II loop (ƒ; n ϭ 11). For the controls, I Ba at ϩ20 mV was Ϫ53.5 Ϯ 8.5 pA/pF, and V 50,act was ϩ6.2 Ϯ 1.5 mV. For cells coexpressing the I-II loop, I Ba at ϩ20 mV was Ϫ50.3 Ϯ 11.4 pA/pF, and V 50,act was ϩ5.1 Ϯ 1.4 mV. f, Steady-state inactivation of I Ba in cells coexpressing GFP-Ca v 2.2 and I-II loop; V 50,inact ϭ Ϫ42.3 Ϯ 1.5 mV; k inact ϭ ϩ6.9 Ϯ 0.7; n ϭ 5; p ϭ NS compared with GFP-Ca v 2.2. g, Cells transfected with GFP-Ca v 2.2 and myc-tagged I-II loop and cotransfected with ␤1b and ␣2␦-1. GFP, GFP fluorescence; myc, immunolocalization of myc-I-II loop using anti-myc Ab; DAPI, DAPI staining of the nucleus; and merge, merged images. h, Cells transfected with GFP-Ca v 2.2 and Dom I-II, in the absence of ␣2␦-1 or ␤1b. GFP, Lack of GFP fluorescence; Phal, Texas Red phalloidin staining; DAPI, DAPI staining of the nuclei; merge, merged images. consistently observed that, within the range examined, reduction of the ␣1 subunit cDNA level decreased the number of cells transfected but not the current density.
To address the mechanism of suppression, we examined whether the suppressive effect of Dom I-II or Dom III-IV on Ca v 2.2 currents could be reduced by coexpression of both hemichannels together with Ca v 2.2, a result that might be predicted because our initial studies showed that Dom I-II and Dom III-IV were able to interact together to form functional channels. A protective effect was confirmed, because the I Ba current density at ϩ20 mV in cells expressing GFP-Ca v 2.2 together with both Dom I-II and Dom III-IV was Ϫ44.4 Ϯ 11.9 pA/pF (n ϭ 9), a nonsignificant 17% reduction ( p ϭ 0.54), compared with Ϫ53.5 Ϯ 8.1 pA/pF Ϫ1 (n ϭ 9) for control GFP-Ca v 2.2 currents (same controls as in Fig. 3e , because experiments performed in parallel).
We next examined whether the mechanism of suppression involved an accelerated degradation of Ca v 2.2, by examining the effect of the 26 S proteasome inhibitor lactacystin. When incubated with cells, at 30 M, either for the entire period between transfection and visualization of GFP-Ca v 2.2, or for the final 16 hr, lactacystin did not increase GFP fluorescence of GFP-Ca v 2.2 coexpressed with Dom I-II (compared with controls receiving the same amount of solvent, n ϭ 6, results not shown).
Is the suppression of expression of GFP-Ca v 2.2 caused by sequestration of ␤ subunits by the truncated constructs?
The Ca v ␤ subunits have been shown to act as chaperone proteins for the calcium channel ␣1 subunits, enhancing their translocation from the endoplasmic reticulum to the plasma membrane (Bichet et al., 2000) . One possible explanation for the suppression of Ca v 2.2 currents is that Dom I-II acts to sequester free ␤1b via its I-II loop, and therefore limits the amount available for chaperoning GFP-Ca v 2.2 to the membrane. To test this hypothesis, cells were transfected with increased ␤1b cDNA, but this did not enhance Ca v 2.2 I Ba recorded in the presence of Dom I-II (Fig.  3d ) (I Ba current density at ϩ20 mV was Ϫ19.4 Ϯ 10.7 pA/pF; n ϭ 8). To examine further whether the effect of Dom I-II on GFPCa v 2.2 was attributable to scavenging of ␤1b by the I-II loop within Dom I-II, we also coexpressed GFP-Ca v 2.2 with a construct of the Ca v 2.2 I-II loop, which we have shown to be capable of binding ␤1b (Bell et al., 2001) . No inhibitory effect was observed (Fig. 3e) ; the I Ba current density at ϩ20 mV in cells expressing GFP-Ca v 2.2 together with the free I-II loop was Ϫ50.3 Ϯ 11.4 pA/pF (n ϭ 11), a nonsignificant 5% reduction, compared with Ϫ53.5 Ϯ 8.1 pA/pF (n ϭ 9) for GFP-Ca v 2.2 currents recorded in parallel, from the same transfections. The steady-state inactivation parameters for GFP-Ca v 2.2 were also unchanged by coexpression with Dom I-II (Fig. 3f ) . In agreement with this, we saw no reduction of GFP-Ca v 2.2 fluorescence when it was coexpressed with the I-II loop, either in the presence or absence of coexpressed ␤1b (Fig. 3g ) (data not shown; n ϭ 2). Furthermore, omission of both coexpressed accessory subunits (␤1b and ␣2␦-1) did not affect the ability of Dom I-II to suppress expression of GFP-Ca v 2.2, as determined by its fluorescence (Fig. 3h) (n ϭ 6) . Because there is very low functional expression of Ca v 2.2 channels in the absence of these accessory subunits (Meir et al., 2000) , it was not possible to perform the corresponding electrophysiological experiments.
In yeast two-hybrid experiments, we observed no interaction of ␤1b with the intracellular N terminus or the C terminus of Ca v 2.2 (n ϭ 3). In every experiment, an interaction of ␤1b with a I-II loop construct was obtained as a positive control (results not shown). This rules out ␤1b subunit scavenging as a mechanism of action of Dom III-IV, which contains the C terminus, but not the I-II loop.
Single channel properties of two domain constructs coexpressed together or with Ca v 2.2
These experiments were performed to determine whether the small whole-cell currents obtained either when Dom I-II was coexpressed with Dom III-IV or when Dom I-II was coexpressed with Ca v 2.2 were caused by altered properties of the channels formed. Single channels were recorded in the cell-attached mode of the patch clamp technique. The recordings were made from COS-7 cells transfected with GFP-Ca v 2.2 alone (Fig. 4a) , Dom I-II together with Dom III-IV (Fig. 4b) , or GFP-Ca v 2.2 with Dom I-II (Fig. 4c) . In all cases we could detect single channels with a similar mean conductance (Fig. 4d) , mean open time (Fig.  4e) , mean closed time (Fig. 4f ) , and latency to first opening ( Fig.  4g; shown at ϩ30 mV). These values are very similar to those obtained from wild-type Ca v 2.2 (not tagged with GFP) (Meir et al., 2000) .
Effect of coexpression of Dom I or the cytoplasmic N terminus on Ca v 2.2 expression
We next investigated the minimal domain required for suppression of Ca v 2.2 expression. To this end, GFP-Ca v 2.2 was coexpressed with either Dom I or the cytoplasmic N terminus of Ca v 2.2. The Dom I construct consisted of the intracellular N terminus, domain I, and the intracellular I-II loop. Immunofluorescence studies using YFP-Dom I confirmed its expression throughout COS-7 cells (results not shown). In a similar manner to Dom I-II, untagged Dom I also appeared to abolish the expression of GFP-Ca v 2.2, as assessed by confocal microscopy ( Fig. 5a) (n ϭ 4) . These results were confirmed by using the anti-GFP Ab, which did not reveal any GFP-Ca v 2.2 (Fig. 5b) (n ϭ 4). Again, this suppression was not affected by the absence of accessory subunits (results not shown; n ϭ 4). In contrast, the N terminus of Ca v 2.2 did not have any effect on the expression of GFP-Ca v 2.2 or on its subcellular localization (Fig. 5c) (n ϭ 4) . GFP-Ca v 2.2 was localized at the plasma membrane (colocalized with phalloidin) and throughout the cytoplasm. In confirmation of these results, I Ba recorded from cells expressing GFP-Ca v 2.2 and Dom I was dramatically reduced, compared with controls (Fig. 5d) . I Ba at ϩ20 mV was Ϫ5.2 Ϯ 1.9 pA/pF (88.4% reduction compared with control; n ϭ 8). In contrast, the I-V parameters for cells expressing GFP-Ca v 2.2 together with the N terminus did not show any decrease in current amplitude or effect on activation (Fig. 5d) . The steady-state inactivation parameters were also identical to those of GFP-Ca v 2.2 (Fig. 5e ). This is in agreement with the lack of interaction observed between the ␤1b subunit and the N terminus of Ca v 2.2 in the yeast two-hybrid assay.
Effect of coexpression of truncated constructs on the Ca v 2.2 protein level
The GFP-Ca v 2.2 expressed alone was detectable by Western blotting using either an anti-GFP Ab or an Ab against the II-III loop of Ca v 2.2 (band at ϳ250 kDa) (Fig. 6a,b, lane 1) . A minor band at 100 kDa was also observed with both Abs, which might therefore represent an N terminal degradation product of Ca v 2.2. When Dom I-II was expressed alone it was detected by antiCa v 2.2, but not anti-GFP Abs (band at 120 kDa in Fig. 6b but not Fig. 6a, lane 2) . However, when GFP-Ca v 2.2 was expressed together with Dom I-II, no band at 250 kDa was observed with either Ab (Fig. 6a,b, lane 3) , although Dom I-II was detected by the anti-Ca v 2.2 Ab, to a similar level as when it was expressed alone (Fig. 6b, compare lanes 2 and 3) . This is in agreement with the confocal imaging data (Fig. 2) . No smaller molecular weight (MW) bands that might represent partially synthesized or degradation products of GFP-Ca v 2.2 were observed when it was cotransfected with Dom I-II, using either Ab (Fig. 6a,b, lane 3) . Neither the 250 and 120 kDa bands nor the 100 kDa putative proteolytic product of GFP-Ca v 2.2 were present in nontransfected cells (Fig. 6a,b, lane 4 ) . Similar results were obtained when GFP-Ca v 2.2 was expressed together with GFP-Dom I-II or Dom I (results not shown). In contrast, in the case of coexpression of GFP-Ca v 2.2 with Dom III-IV, there was little, if any, reduction in the amount of GFP-Ca v 2.2 (Fig. 6c, compare lanes 1 and 3) , in agreement with the confocal imaging data (Fig. 2g) .
DISCUSSION
It has been suggested that four-domain Na ϩ and Ca 2ϩ channels arose during evolution from two sequential gene duplications of a K ϩ channel (Plummer et al., 1997) and that expression of the two-domain isoforms still occurs in a developmentally regulated manner (Plummer et al., 1997) . It is possible that the two-domain isoforms of Ca v 1.1, Ca v 1.2, and the Na ϩ channel SCN8A may all serve a similar function (Plummer et al., 1997) . It would be predicted from our results that this would be a dominant-negative function, to suppress expression of the full-length channel. In support of this, a three-domain construct of an ascidian calcium channel, thought to be expressed from maternal transcript, has in a) . c, Single-channel activity from a cell transfected with GFP-Ca v 2.2 and Dom I-II (in a patch with no overlapping openings, format as in a). d-g, The symbols used represent the transfection conditions described in a (F; GFP-Ca v 2.2), b (⌬; GFP-Dom I-II and Dom III-IV), and c (Ⅺ; GFP-Ca v 2.2 and Dom I-II). d, Unitary I-V relationships for the three conditions (F; nϭ 10), (⌬; n ϭ 5), and (Ⅺ; n ϭ 11). These were fit by linear regression (the lines here are the average fit in each condition). The single channel conductance was 12.6 Ϯ 1.0, 11.6 Ϯ 1.2, and 13.8 Ϯ 1.0 pS for the three conditions, respectively. e, Voltage dependence of mean channel open times (see Materials and Methods) for the three conditions (F; n ϭ 8), (⌬; n ϭ 5), and (Ⅺ; n ϭ 11). f, Voltage dependence of mean channel closed times for the three conditions (F; n ϭ 2), (⌬; n ϭ 1), and (Ⅺ; n ϭ 5). g, Latency to first opening (see Materials and Methods) in response to ϩ30 mV test pulse for the three conditions (F; n ϭ 4), (⌬; n ϭ 5), and (Ⅺ; n ϭ 4).
recently been shown to suppress expression of the full-length ascidian calcium channel (Okagaki et al., 2001) . Dominant-negative suppression of K ϩ channel tetramer function by transmembrane fragments has been studied previously for the K v channel family (Tu et al., 1995) . This suppression effect was found to involve multiple transmembrane peptides but not to affect synthesis (Tu et al., 1996) . As discussed in that study, the formation of K ϩ channel tetramers will involve multiple interactions between domains, and disruption at any stage of biogenesis may be sufficient to cause suppression of functional expression (Tu et al., 1996) . In contrast, another recent study showed the existence of a pathway involving arrest of synthesis and rapid degradation of mis-folded human ether-a-go-go-related gene (HERG) K ϩ channel tetramers induced by a point mutation (Kagan et al., 2000) .
Here we have examined whether the mechanism of suppression of expression of full-length Ca v 2.2 by truncated constructs involves (1) interference with gating of the channel inserted in the plasma membrane, (2) interference with delivery to the plasma membrane, (3) increased protein degradation, or (4) synthesis arrest. Below we consider these possibilities in turn.
Is there an impairment of gating caused by association of channel fragments with full-length Ca v 2.2 in the plasma membrane? From the electrophysiological data, GFP-Dom I-II coexpressed with Dom III-IV resulted in small but reproducible whole-cell calcium channel currents and produced single channels whose properties, apart from frequency of observation, were indistinguishable from wild type. Therefore, at least a small proportion of the truncated constructs must be able to fold and assemble together correctly with the normal topology. Similar results have recently been obtained for coexpression of two domain constructs of Ca v 1.1 (Ahern et al., 2001) . Concerning the mechanism of suppression, a combination of the whole-cell and single channel analysis indicates that the inhibition of full-length Ca v 2.2 currents by Dom I-II is attributable to a reduction in the number of channels, because there is no alteration in any of their biophysical properties examined. Although fewer Ca v 2.2 channels reach the plasma membrane, their gating is not modified by an association with the truncated construct. The apparent discrepancy between the confocal imaging data, where almost no GFP fluorescence was seen when Dom I-II was coexpressed with GFP-Ca v 2.2, and the electrophysiological data, may be a function of the detection limit, which has been calculated to be ϳ10,000 GFP molecules per tissue culture cell (Patterson et al., 1997) . From our data, only ϳ3000 channels would be required to give rise to the currents observed when Dom I-II is coexpressed with GFP-Ca v 2.2. It is also possible that the GFP tag is synthesized, but mis-folded, and therefore not fluorescent, but it was also not recognized by the GFP Ab.
Is there interference in the delivery of the channel to the plasma membrane? Ca v ␤ subunits are involved both in trafficking ␣1 subunits and in modulating their biophysical properties (Chien et al., 1995; Brice et al., 1997; Bichet et al., 2000; Canti et al., 2001) . It is conceivable that trafficking of Ca v 2.2 through the endoplasmic reticulum might be compromised by scavenging of Ca v ␤ subunits by the truncated fragments. However, suppression was not prevented by expression of an increased amount of ␤ subunit. Furthermore, the properties of the currents in the pres- -V relationships for GFP-Ca v 2.2 alone (F, n ϭ 7; I Ba ϭ Ϫ44.8 Ϯ 8.9 pA/pF at ϩ20 mV; V 50,act ϭ ϩ6.4 Ϯ 2.1 mV); GFP-Ca v 2.2 plus N terminus (E, n ϭ 11; I Ba ϭ Ϫ44.9 Ϯ 8.6 pA/pF at ϩ20 mV; V 50,act ϭ ϩ8.9 Ϯ 1.8 mV; p ϭ NS) or GFP-Ca v 2.2 plus Dom I (, n ϭ 8; I Ba ϭ Ϫ5.2 Ϯ 1.9 pA/pF at ϩ20 mV; V 50,act ϭ ϩ14.7 Ϯ 1.5 mV; both p Ͻ 0.001 compared with control). e, Steady-state inactivation curve (fitted with a Boltzmann function, solid line) for GFP-Ca v 2.2 plus N terminus (E; V 50,inact ϭ Ϫ42.0 Ϯ 0.7 mV; k inact ϭ 7.9 Ϯ 0.7; n ϭ 5). Data are superimposed on the Boltzmann fit for the steady-state inactivation curve for GFP-Ca v 2.2 from ence of the truncated constructs did not mimic those of Ca v 2.2 expressed without ␤ subunits in COS-7 cells or Xenopus oocytes, where both the V 50 for activation and steady-state inactivation were markedly depolarized (Canti et al., 2000; Meir et al., 2000; Stephens et al., 2000) . Moreover, suppression of GFP-Ca v 2.2 protein expression remained evident in the absence of coexpressed accessory ␤ subunits, indicating that it occurs before trafficking out of the endoplasmic reticulum [for which Ca v ␤ is required (Bichet et al., 2000) ]. From yeast two-hybrid experiments we found that, of the intracellular I-II loop, the N terminus and the C terminus of Ca v 2.2, only the I-II loop represents a high-affinity interaction site for ␤1b. However, coexpression of the I-II loop with Ca v 2.2 did not reduce Ca v 2.2 I Ba , again indicating that scavenging of ␤ subunits is not responsible for the suppressive effect of Dom I and Dom I-II. The lack of effect of the I-II loop, either to reduce expression or to affect the V 50 for activation is presumably because the ␤ subunit is present in excess, as also demonstrated in our recent study in Xenopus oocytes, where the maximum effect of ␤3 on expression occurred at ϳ6 pg of ␤3 cDNA for 540 pg of Ca v 2.2 cDNA injected per oocyte (Canti et al., 2001) .
Another potential mechanism of suppression would be prevention of correct folding of Ca v 2.2 by the truncated domains, so that endoplasmic reticulum retention signals are not masked, and the mis-folded channel is retained in the endoplasmic reticulum. Although this may be the mechanism of Ca v 2.2 suppression by the Dom III-IV construct, where loss of Ca v 2.2 protein was not observed (Figs. 2g, 6c ), in the case of the truncated constructs containing domain I, instead of observing an accumulation of the GFP-Ca v 2.2 signal in the endoplasmic reticulum, we observed an almost complete loss of GFP-Ca v 2.2 fluorescence (Figs. 2b, d, 5a, b) .
This points to decreased synthesis or stability of the Ca v 2.2 protein. In experiments to distinguish between these possibilities, we found that inhibition of proteasome activity by lactacystin did not increase the amount of GFP-Ca v 2.2 observed in the presence of Dom I-II, suggesting that the mechanism does not involve enhanced proteolysis, in contrast to the finding with the HERG K ϩ channel mutant (Kagan et al., 2000) . From these results, the most likely explanation for suppression by truncated constructs containing domain I is that synthesis of full-length Ca v 2.2 is arrested. Furthermore, the intracellular N terminus alone was ineffective, suggesting that suppression may occur by interaction of the nascent transmembrane segments of the first domain of Ca v 2.2 with Dom I of the truncated construct. Synthesis of polytopic proteins passes through a state where up to six nascent transmembrane ␣-helices span the endoplasmic reticulum membrane, but are not yet integrated in its lipid bilayer, associating via ionic rather than hydrophobic interactions (Borel and Simon, 1996) . When the initial transmembrane ␣-helices of Ca v 2.2 are in this state, it may be that interference occurs with further synthesis of the full-length channel, because of interaction with the Dom I and Dom I-II proteins, where, in the absence of all four transmembrane domains for assembly, inappropriate residues would remain exposed. It is possible that this would effectively halt polysomal movement on each Ca v 2.2 mRNA. The lack of effect of the Dom III-IV construct to suppress synthesis of Ca v 2.2 could be attributed to the fact that synthesis and assembly of Ca v 2.2 is nearer completion before the interaction occurs with transmembrane segments of Dom III-IV, which then results in trapping in the endoplasmic reticulum. Furthermore, the fact that there is a reduction, rather than an increase, in suppression when Dom I-II and Dom III-IV are together coexpressed with Ca v 2.2, also points to the exposure of inappropriate residues on the singly expressed hemichannels as a mechanism of suppression.
In agreement with the hypothesis that synthesis of Ca v 2.2 is suppressed, we observed loss of full-length GFP-Ca v 2.2 protein, when it was coexpressed with either Dom I-II or Dom I. Furthermore, no smaller MW partially synthesized or degradation products of Ca v 2.2 were observed. This also points to synthesis arrest at an early stage, rather than enhanced degradation. However, although attenuation of translation is a well established aspect of the unfolded protein response that occurs when there is an accumulation of mis-folded proteins in the endoplasmic reticulum (Chevet et al., 2001) , in the present case the synthesis inhibition was specific to Ca v 2.2, because coexpression of Ca v 2.2 did not appear to reduce the level of Dom I-II, and this may therefore be a novel mechanism. We are currently examining whether the Ca v 2.2 mRNA level is reduced, and if so, whether this is a primary event, or a consequence of synthesis inhibition.
In conclusion, it is likely that early in the process of synthesis, if Ca v 2.2 associates with domain I of the truncated constructs in the endoplasmic reticulum membrane, translation of the fulllength Ca v 2.2 channel is largely prevented. This finding may generalize to all normally or pathologically occurring calcium channel splice variants that form such truncated proteins and represent a physiological mechanism for developmental or tissuespecific channel expression.
